Clinical Trial Update: Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL [Phase 2]

View source ↗

Summary

Phase 2 trial update examining whether adding low-intensity chemotherapy to a short course of blinatumomab improves outcomes for adults with Philadelphia-negati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Xianmin Song, MD | Conditions: Acute Lymphoid Leukemia (ALL) | Phase 2 | Status: NOT_YET_RECRUITING